Document Detail


The relationship of weight change to changes in blood pressure, serum uric acid, cholesterol and glucose in the treatment of hypertension.
MedLine Citation:
PMID:  3889027     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In the Hypertension Detection and Follow-up Program (HDFP), elevated blood pressure (BP) was treated by rigorous, stepped care (SC) therapy among half the participants, while the other half were referred to usual sources of care (referred care, RC). There was no program to reduce weight, however, some participants changed weight voluntarily over the first 2 yr, providing an opportunity to examine the role of weight change in the development of diuretic-induced hyperuricemia, hyperglycemia and hypercholesterolemia. There was a stepwise progression from decreased glucose, uric acid and cholesterol concentrations, and BP associated with maximum weight loss to increased values with maximum weight gain. In SC, systolic BP declined by 22.4% among weight-losers and by 17.1% among weight-gainers; in RC, it was 14.4 and 8.1%, respectively. The pattern in diastolic blood pressure and weight change was similar but not as marked. These findings suggest the potential importance of weight loss in enhancing effectiveness of antihypertensive drug treatment and attenuating increases in glucose, uric acid, and cholesterol associated with diuretic treatment of hypertension. The weight change analyses are based on postrandomization observations and do not reflect experimental changes.
Authors:
S Heyden; N O Borhani; H A Tyroler; K A Schneider; H G Langford; C G Hames; R Hutchinson; A Oberman
Related Documents :
10100687 - What is the role of obesity in hypertension and target organ injury in african americans?
16141297 - Birthweight and blood pressure in five european birth cohort studies: an investigation ...
10711667 - Pre-operative control of arterial hypertension using ketoconazole in pediatric patients...
12623937 - Cardiac transcriptome analysis in obesity-related hypertension.
1611437 - Mechanism of action of external compression on venous function.
16035797 - Wetting kinetics of films containing nonadsorbing polymers.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of chronic diseases     Volume:  38     ISSN:  0021-9681     ISO Abbreviation:  J Chronic Dis     Publication Date:  1985  
Date Detail:
Created Date:  1985-07-08     Completed Date:  1985-07-08     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  2985123R     Medline TA:  J Chronic Dis     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  281-8     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blood Glucose / analysis*
Blood Pressure
Body Weight*
Chlorthalidone / therapeutic use
Cholesterol / blood*
Clinical Trials as Topic
Diuretics / therapeutic use*
Female
Follow-Up Studies
Humans
Hypertension / blood,  drug therapy*,  physiopathology
Male
Random Allocation
Time Factors
Uric Acid / blood*
Grant Support
ID/Acronym/Agency:
N01-HV-12433-42/HV/NHLBI NIH HHS; N01-HV-22931, 37-39, 45/HV/NHLBI NIH HHS; N01-HV-32933/HV/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Blood Glucose; 0/Diuretics; 57-88-5/Cholesterol; 69-93-2/Uric Acid; 77-36-1/Chlorthalidone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A new technic of cutaneous suture. The SAFE technic (Suture, Assisted by adhesive Film, for Esthetic...
Next Document:  Glucose metabolism in noninsulin-dependent diabetic patients with experimental hyperthyroidism.